Skip to main content
Congenital heart disease (CHD) defines any malformation of the cardiovascular system present at birth with an incidence of 1% of live births.1 Although several recent studies have performed exome or genome sequencing to identify the genetic causes of CHD, a comprehensive resource of genes linked to CHD causation is not currently available. Studies often use candidate gene lists but do not provide sufficient information, such as original citations, on how these are generated. Additionally, studies frequently use gene lists that are not curated but automatically extracted by gene disease databases such as ClinVar or OMIM. Automated gene list generation might miss genes associated with CHD or include genes not supported by enough evidence. As a result, this hinders the identification of clinically reportable or actionable variants in affected patients.
We have developed CHDgene (http://chdgene.victorchang.edu.au/): a curated database that contains essential information about the genes that have been reproducibly shown to cause CHD when mutated in humans. An initial version of our database has been used by the first genome-sequencing study of patients with CHD that identified a reportable variant in 31% of families.2 Given that the majority of patients with CHD do not currently receive a genetic diagnosis, many more genes are expected to be involved in CHD causation, with a recent estimate of ≈440 genes inferred to contribute to sporadic CHD.3 The search for genetic causes of CHD requires a constantly up-to-date resource on the genetics of CHD. CHDgene provides this, and as our multidisciplinary team continues to investigate the genetics of CHD, we commit to keeping this information up-to-date.
The criteria for inclusion of a gene in our database as a CHD gene are strict to ensure that variants in these genes are clinically actionable.4 Genes are only included in the database if variants in the respective gene have been reported as the monogenic cause for CHD (isolated or in the context of a syndrome) in at least 3 independent familial or sporadic cases in one or more separate publications.
CHDgene provides useful information about the genes linked to CHD causation: classification of cardiac malformations, whether variants can cause extracardiac phenotypes, modes of inheritance of variants in the genes, presence of incomplete penetrance or variable expressivity, the corresponding pathogenic and likely pathogenic variants as reported on ClinVar and information on animal models (Figure).
Figure. Overview of the CHDgene database. A, Home page of the CHDgene database. B, Page for NOTCH1 gene. ACMG indicates American College of Medical Genetics and Genomics.
CHDgene was developed in Python 3 using Flask web framework and MySQL 5.7 database engine. The server-side application was implemented in Python using python packages including SQLAlchemy and mysqlclient for interacting with the database engine. The web interface was developed with Bootstrap. The gene list table was implemented using the tablesorter jQuery plug-in. Finally, igv.js library was used to embed the Integrative Genomics Viewer genome browser for visualizing variants from ClinVar.
CHDgene provides comprehensive information that can be used for the identification of clinically reportable variants according to the guidelines of the American College of Medical Genetics and Genomics5 and thereby facilitates genetic diagnosis of CHD. At the same time, CHDgene can serve as a useful resource for any cardiovascular disease researcher as it provides valuable information on disease genes and their associated phenotypes.

Footnote

Nonstandard Abbreviations and Acronyms

CHD
congenital heart disease

References

1.
Nees SN, Chung WK. Genetic basis of human congenital heart disease. Cold Spring Harb Perspect Biol. 2020;12:a036749. doi: 10.1101/cshperspect.a036749
2.
Alankarage D, Ip E, Szot JO, Munro J, Blue GM, Harrison K, Cuny H, Enriquez A, Troup M, Humphreys DT, et al. Identification of clinically actionable variants from genome sequencing of families with congenital heart disease. Genet Med. 2019;21:1111–1120. doi: 10.1038/s41436-018-0296-x
3.
Jin SC, Homsy J, Zaidi S, Lu Q, Morton S, DePalma SR, Zeng X, Qi H, Chang W, Sierant MC, et al. Contribution of rare inherited and de novo variants in 2,871 congenital heart disease probands. Nat Genet. 2017;49:1593–1601. doi: 10.1038/ng.3970
4.
Szot JO, Cuny H, Blue GM, Humphreys DT, Ip E, Harrison K, Sholler GF, Giannoulatou E, Leo P, Duncan EL, et al. A screening approach to identify clinically actionable variants causing congenital heart dsease in exome data. Circ Genom Precis Med. 2018;11:e001978. doi: 10.1161/CIRCGEN.117.001978
5.
Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, et al; ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–424. doi: 10.1038/gim.2015.30

eLetters(0)

eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate.

Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page.

Information & Authors

Information

Published In

Go to Circulation: Genomic and Precision Medicine
Go to Circulation: Genomic and Precision Medicine
Circulation: Genomic and Precision Medicine
Pages: e003539
PubMed: 35522174

Versions

You are viewing the most recent version of this article.

History

Published online: 6 May 2022
Published in print: June 2022

Permissions

Request permissions for this article.

Keywords

  1. cardiovascular system
  2. data management
  3. exome
  4. genome
  5. heart diseases

Subjects

Authors

Affiliations

Victor Chang Cardiac Research Institute, Darlinghurst, Australia (A.Y., D.A., H.C., E.K.K.I., M.A., J.L., D.D., A.E., J.O.S., D.T.H., G.M.B., S.L.D., E.G.).
Victor Chang Cardiac Research Institute, Darlinghurst, Australia (A.Y., D.A., H.C., E.K.K.I., M.A., J.L., D.D., A.E., J.O.S., D.T.H., G.M.B., S.L.D., E.G.).
Hartmut Cuny, PhD
Victor Chang Cardiac Research Institute, Darlinghurst, Australia (A.Y., D.A., H.C., E.K.K.I., M.A., J.L., D.D., A.E., J.O.S., D.T.H., G.M.B., S.L.D., E.G.).
Victor Chang Cardiac Research Institute, Darlinghurst, Australia (A.Y., D.A., H.C., E.K.K.I., M.A., J.L., D.D., A.E., J.O.S., D.T.H., G.M.B., S.L.D., E.G.).
Moran Almog, MD
Victor Chang Cardiac Research Institute, Darlinghurst, Australia (A.Y., D.A., H.C., E.K.K.I., M.A., J.L., D.D., A.E., J.O.S., D.T.H., G.M.B., S.L.D., E.G.).
Victor Chang Cardiac Research Institute, Darlinghurst, Australia (A.Y., D.A., H.C., E.K.K.I., M.A., J.L., D.D., A.E., J.O.S., D.T.H., G.M.B., S.L.D., E.G.).
UNSW Sydney, Kensington, Australia (E.K.K.I., J.L., A.E., D.T.H., S.L.D., E.G.).
Debjani Das, PhD
Victor Chang Cardiac Research Institute, Darlinghurst, Australia (A.Y., D.A., H.C., E.K.K.I., M.A., J.L., D.D., A.E., J.O.S., D.T.H., G.M.B., S.L.D., E.G.).
Annabelle Enriquez, MBBS https://orcid.org/0000-0003-4684-9889
Victor Chang Cardiac Research Institute, Darlinghurst, Australia (A.Y., D.A., H.C., E.K.K.I., M.A., J.L., D.D., A.E., J.O.S., D.T.H., G.M.B., S.L.D., E.G.).
UNSW Sydney, Kensington, Australia (E.K.K.I., J.L., A.E., D.T.H., S.L.D., E.G.).
Victor Chang Cardiac Research Institute, Darlinghurst, Australia (A.Y., D.A., H.C., E.K.K.I., M.A., J.L., D.D., A.E., J.O.S., D.T.H., G.M.B., S.L.D., E.G.).
Victor Chang Cardiac Research Institute, Darlinghurst, Australia (A.Y., D.A., H.C., E.K.K.I., M.A., J.L., D.D., A.E., J.O.S., D.T.H., G.M.B., S.L.D., E.G.).
UNSW Sydney, Kensington, Australia (E.K.K.I., J.L., A.E., D.T.H., S.L.D., E.G.).
Victor Chang Cardiac Research Institute, Darlinghurst, Australia (A.Y., D.A., H.C., E.K.K.I., M.A., J.L., D.D., A.E., J.O.S., D.T.H., G.M.B., S.L.D., E.G.).
Heart Centre for Children, The Children’s Hospital at Westmead, Australia (G.M.B.).
Sydney Medical School, The University of Sydney, Australia (G.M.B.).
School of Biomedical Sciences, University of Hong Kong (J.W.K.H.).
Laboratory for Data Discovery for Health (D24H), Hong Kong Science Park (J.W.K.H.).
David S. Winlaw, MBBS, MD https://orcid.org/0000-0001-8005-3361
Heart Institute, Cincinnati Children’s Hospital Medical Center, OH (D.S.W.).
Victor Chang Cardiac Research Institute, Darlinghurst, Australia (A.Y., D.A., H.C., E.K.K.I., M.A., J.L., D.D., A.E., J.O.S., D.T.H., G.M.B., S.L.D., E.G.).
UNSW Sydney, Kensington, Australia (E.K.K.I., J.L., A.E., D.T.H., S.L.D., E.G.).
Victor Chang Cardiac Research Institute, Darlinghurst, Australia (A.Y., D.A., H.C., E.K.K.I., M.A., J.L., D.D., A.E., J.O.S., D.T.H., G.M.B., S.L.D., E.G.).
UNSW Sydney, Kensington, Australia (E.K.K.I., J.L., A.E., D.T.H., S.L.D., E.G.).

Notes

*
A. Yang and D. Alankarage contributed equally.
For Sources of Funding and Disclosures, see page 253.
Correspondence to: Eleni Giannoulatou, PhD, Computational Genomics Laboratory, Victor Chang Cardiac Research Institute, 405 Liverpool St, Darlinghurst, NSW 2010, Australia, Email [email protected]
Correspondence to: Sally L. Dunwoodie, PhD, Embryology Laboratory, Victor Chang Cardiac Research Institute, 405 Liverpool St, Darlinghurst, NSW 2010, Australia, Email [email protected]

Disclosures

Disclosures None.

Sources of Funding

This work was supported by National Health and Medical Research Council (NHMRC), Australia Synergy Grant to S.L. Dunwoodie, E. Giannoulatou, Dr Winlaw (1181325). E. Giannoulatou is supported by a NSW Health Early Mid Career Fellowship, a NSW Health Early Mid Career Fellowship, a NSW Health Early Mid Career Cardiovascular Grant and a National Heart Foundation of Australia Future Leader Fellowship (101204). S.L. Dunwoodie is supported by an NHMRC Principal Research Fellowship (1135886) and a NSW Health Cardiovascular Senior Scientist Grant. M. Almog was supported by a AUSiMED (Australia-Israel) Fellowship.

Metrics & Citations

Metrics

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

  1. Identification of Long Noncoding RNA Candidate Disease Genes Associated With Clinically Reported Copy Number Variants in Congenital Heart Disease, Journal of the American Heart Association, 14, 6, (2025)./doi/10.1161/JAHA.124.039177
    Abstract
  2. Machine Learning in Identifying Marker Genes for Congenital Heart Diseases of Different Cardiac Cell Types, Life, 14, 8, (1032), (2024).https://doi.org/10.3390/life14081032
    Crossref
  3. Beyond genomic studies of congenital heart defects through systematic modelling and phenotyping, Disease Models & Mechanisms, 17, 11, (2024).https://doi.org/10.1242/dmm.050913
    Crossref
  4. A validated heart-specific model for splice-disrupting variants in childhood heart disease, Genome Medicine, 16, 1, (2024).https://doi.org/10.1186/s13073-024-01383-8
    Crossref
  5. NODAL variants are associated with a continuum of laterality defects from simple D-transposition of the great arteries to heterotaxy, Genome Medicine, 16, 1, (2024).https://doi.org/10.1186/s13073-024-01312-9
    Crossref
  6. The Kids Heart BioBank: supporting 20 years of patient care and research into CHD, Cardiology in the Young, 34, 8, (1645-1652), (2024).https://doi.org/10.1017/S1047951124025654
    Crossref
  7. Congenital heart diseases (CHDs) and forensic investigations: Searching for the cause of death, Experimental and Molecular Pathology, 137, (104907), (2024).https://doi.org/10.1016/j.yexmp.2024.104907
    Crossref
  8. Progresses in genetic testing in congenital heart disease, Medicine Plus, 1, 2, (100028), (2024).https://doi.org/10.1016/j.medp.2024.100028
    Crossref
  9. CHDTEPDB: Transcriptome Expression Profile Database and Interactive Analysis Platform for Congenital Heart Disease, Congenital Heart Disease, 18, 6, (693-701), (2023).https://doi.org/10.32604/chd.2024.048081
    Crossref
  10. Noncanonical Splice-Altering Variants: Hidden Culprits of Congenital Heart Disease, Circulation: Genomic and Precision Medicine, 16, 3, (232-235), (2023)./doi/10.1161/CIRCGEN.123.004148
    Abstract
  11. See more
Loading...

View Options

View options

PDF and All Supplements

Download PDF and All Supplements

PDF/EPUB

View PDF/EPUB
Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

Purchase this article to access the full text.

Purchase access to this article for 24 hours

CHDgene: A Curated Database for Congenital Heart Disease Genes
Circulation: Genomic and Precision Medicine
  • Vol. 15
  • No. 3

Purchase access to this journal for 24 hours

Circulation: Genomic and Precision Medicine
  • Vol. 15
  • No. 3
Restore your content access

Enter your email address to restore your content access:

Note: This functionality works only for purchases done as a guest. If you already have an account, log in to access the content to which you are entitled.

Figures

Tables

Media

Share

Share

Share article link

Share

Comment Response